Therefore, the reduced level of DNase I, observed in the group of patients with mild psoriasis, may be related to the activity of inhibitors and/or insufficient stimulation by NETs (reduced levels of NE-DNA and physiological levels of MPO-DNA and citrullinated histones). The gene discussed is MPO; the disease is psoriasis.